New therapeutic uses of (4-(2-Fluorophenyl)-6-methyl-2-(1-piper azinyl) thieno[2,3-D]pyrimidine

Details for Australian Patent Application No. 2003259373 (hide)

International Classifications

Event Publications

13 November 2003 Complete Application Filed

Priority application(s): 0220064.0 29.08.02 GB; 0316115.5 09.07.03 GB

6 May 2004 Application Open to Public Inspection

Published as AU-B-2003259373

9 March 2006 Application Accepted

Published as AU-B-2003259373

29 June 2006 Opposition Lodged

Dynogen Pharmaceuticals, Inc. has lodged an opposition against Arachnova Therapeutics Ltd.

23 August 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 11 May 2007. Address for service in Australia - Madderns 1st Floor 64 Hindmarsh Square Adelaide SA 5000

20 December 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 11 May 2007

10 January 2008 Opposition Withdrawn

The opposition by Dynogen Pharmaceuticals, Inc. against Arachnova Therapeutics Ltd has been withdrawn.

14 February 2008 Assignment before Grant

Arachnova Therapeutics The application has been assigned to Dynogen Pharmaceuticals, Inc.

28 February 2008 Standard Patent Sealed

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.